腺病毒载体疫苗即刻先天免疫应答的纵向多组学分析与皮质类固醇调节
研究基于单细胞转录组和单核细胞表观基因组,分析ChAdOx1 nCoV-19疫苗接种后免疫景观,发现表达干扰素刺激基因的单核细胞和先天样活化T细胞在接种后1天增加、14天回落基线,口服皮质类固醇预处理可降低主要ISG染色质可及性从而削减炎症反应且不损害免疫原性。
要点
- 接种后1天ISG表达单核细胞和先天样活化T细胞增多,出现不同亚型,14天回落基线。
- 口服皮质类固醇预处理降低主要ISG染色质可及性,削减ISG相关炎症反应。
- 皮质类固醇预处理未损害疫苗免疫原性。
核心结论
- 研究揭示ChAd载体疫苗接种后人类免疫应答特征,并提出可减少炎症副作用的方法。
研究设计与样本
- 基于免疫细胞单细胞转录组和单核细胞表观基因组谱,全面检查ChAdOx1 nCoV-19接种后免疫景观。
主要发现
- 表达干扰素刺激基因(ISG)的单核细胞和先天样活化T细胞在接种后1天增加,出现不同亚型ISG活化细胞,14天回落基线。
- 口服皮质类固醇预处理通过降低主要ISG染色质可及性有效削减ISG相关炎症反应,且未损害疫苗免疫原性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Among new vaccine technologies contributed to the control of the COVID-19 pandemic, ChAdOx1 nCoV-19, a chimpanzee adenovirus (ChAd)-vector vaccine expressing the SARS-CoV-2 spike protein, could be administered globally owing to its low production cost and lack of a requirement for frozen storage. Despite its benefits, most recipients have reported immediate inflammatory reactions after the initial dose vaccination. We comprehensively examined the immune landscape following ChAdOx1 nCoV-19 vaccination based on the single-cell transcriptomes of immune cells and epigenomic profiles of monocytes. Monocyte and innate-like activated T cell populations expressing interferon-stimulated genes (ISGs) increased 1 day post-vaccination with appearance of distinct subtype of ISG-activated cells, returning to baseline by day 14. Pre-treatment with oral corticosteroids effectively curtailed these ISG-associated inflammatory responses by decreasing chromatin accessibility of major ISGs, without hampering vaccine immunogenicity. Our findings provide insights into the human immune response following ChAd-based vaccination and propose a method to reduce inflammatory side effects.
引用
- Jin Choi S, Lee W, Cheol Kim S, et al. Longitudinal multiomic profiling and corticosteroid modulation of the immediate innate immune response to an adenovirus-vector vaccine. Vaccine. 2024. PMID: 39025696. doi:10.1016/j.vaccine.2024.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。